Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Myelodysplastic Syndromes 33Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Myeloproliferative Disorders 18Leukemia, Biphenotypic, Acute 18Hematologic Neoplasms 18Leukemia, Lymphocytic, Chronic, B-Cell 16Lymphoma, Non-Hodgkin 15Hodgkin Disease 15Multiple Myeloma 14Leukemia, Myelomonocytic, Chronic 13Leukemia 12Anemia, Refractory, with Excess of Blasts 11Primary Myelofibrosis 10Lymphoma, Follicular 10Lymphoma, Mantle-Cell 9Burkitt Lymphoma 9Lymphoma, B-Cell, Marginal Zone 8Lymphoma 8Lymphoma, T-Cell 7Leukemia, Prolymphocytic 7Anemia, Aplastic 7Leukemia, Myeloid 6Graft vs Host Disease 6Waldenstrom Macroglobulinemia 5Polycythemia Vera 5Lymphoma, Large B-Cell, Diffuse 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Accelerated Phase 4

Interventions

Azacitidine 2aldesleukin 1Whole-Body Irradiation 1Vorinostat 1Peripheral Blood Stem Cell Transplantation 1Idarubicin 1Gemtuzumab 1Filgrastim 1Etoposide 1Cytarabine 1Busulfan 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Erythroblastic, Acute × Whole-Body Irradiation × 1 year × Clear all
NCT00534469 2025-12-02

Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R

City of Hope Medical Center

Phase 2 Completed
60 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡